Northwire Canada EditionThursday, October 15, 2026
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Earnings Material −

Telescope Innovations Provides Financial Results of Third Fiscal Quarter 2026

Triple-digit pre-earnings run meets a wall of cash burn and a quiet going-concern clause.

Executive Summary

Telescope Innovations reported Q3 FY2026 (quarter ended May 31, 2026) financial results. Revenues were $2.12 million CAD, up from $1.39 million in the prior-year quarter. Year-to-date gross revenues reached $6.5 million CAD, representing 80% growth versus the same period last year. The adjusted EBITA loss widened to $1.06 million from $0.10 million a year ago. Operating highlights include securing a third Self-Driving Lab (SDL) contract with a major European pharmaceutical company, a collaboration agreement with AGI Group to integrate DirectInject‑LC™ into automated reactor systems, and invoicing for a DirectInject‑IC™ platform for lithium battery materials purification. Management attributed the rising expenses to investments in talent, infrastructure, marketing, and product development.

Material Impact

The Q3 release contains genuinely positive commercial progress – a third major SDL order and expanding partnerships. However, the financial reality is stark: losses are deepening, cash burn is accelerating, and the company’s own filings carry an explicit going‑concern warning. The stock’s +131.6% run into the print suggests the market expected a blowout that would justify the elevated price; instead, the widening loss and the MD&A’s warning about tariff‑driven order uncertainty represent a significant negative surprise. Critically, the press release omitted any mention of the going‑concern risk, which fundamentally changes the investment case. The combination of a stretched valuation, a mixed track record, and the undisclosed survival risk makes this a materially negative event relative to market‑implied expectations.

TELI · Price
Company Overview

Telescope Innovations Corp. is a commercial‑stage laboratory automation company that develops Self‑Driving Labs (SDLs) – integrated robotic, analytical, and AI platforms for autonomous chemical experimentation. It also commercializes advanced analytical instruments (DirectInject‑LC™/IC/ICP) and has a lithium processing technology portfolio (ReCRFT™, DualPure™) targeting battery‑material recycling and production. The company is headquartered in Vancouver, Canada, and trades on the Canadian Securities Exchange.

Read the original news release →

More from Telescope Innovations Corp.